Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - budesonidum - rektalschaum - budesonidum 2 mg, propylenglycolum 600.3 mg, alcohol cetylicus et stearylicus 12.6-15.12 mg, polysorbatum 60, macrogoli 10 aether stearylicus, alcohol cetylicus 8.4 mg, acidum citricum monohydricum, dinatrii edetas, aqua purificata ad emulsionem pro dosi, propellentia: butanum, isobutanum, propanum. - la colite ulcéreuse - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - budesonidum - magensaftresistentes granulat - budesonidum 9 mg, sacchari sphaerae corresp. saccharum 828 mg, lactosum monohydricum 36 mg, povidonum k 25, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum b, ammonio methacrylatis copolymerum a, triethylis citras, talcum, aromatica zitrone cum citralum et citronellolum et limonenum et geraniolum et linaloolum, xanthani gummi, sorbitolum 899.5 mg, acidum citricum, sucralosum, magnesii stearas, ad granulatum pro charta. - morbus crohn, kollagene colitis - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - salicylicium ursodeoxycholicum - capsules - acidum ursodeoxycholicum 250 mg, maydis amylum, silica colloidalis anhydrica, magnesii stearas, kapselhülle: e 171, gelatina, aqua purificata, natrii laurilsulfas, pro capsula corresp. natrium 0.016 mg. - auflösung von gallensteinen - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - salicylicium ursodeoxycholicum - suspension - acidum ursodeoxycholicum 250 mg, aqua purificata, xylitolum, glycerolum, cellulosum microcristallinum et carmellosum natricum, propylenglycolum 50 mg, natrii citras dihydricus, acidum citricum, natrii chloridum, natrii cyclamas, aromatica (lemon), e 210 7.5 mg ad suspensionem pro 5 ml corresp. natrium 11.1 mg. - auflösung von gallensteinen - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - budesonidum - capsules - budesonidum 3 mg, sacchari sphaerae corresp. saccharum 276 mg et maydis amylum, lactosum monohydricum 12 mg, povidonum k 25, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum b, ammonio methacrylatis copolymerum a, triethylis citras, talcum, kapselhülle: gelatina, e 172 (rubrum), e 171, e 127, e 172 (nigrum), natrii laurilsulfas corresp. natrium 0.006 mg, pro capsula. - morbus chron, kollagene colitis - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - salicylicium ursodeoxycholicum - comprimés pelliculés - acidum ursodeoxycholicum 500 mg, cellulosum microcristallinum, povidonum k 25, crospovidonum, talcum, magnesii stearas, silica colloidalis anhydrica, polysorbatum 80, Überzug: hypromellosum, talcum, macrogolum 6000 pro compresso obducto. - auflösung von gallensteinen - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - comprimés pelliculés - mesalazinum 1000 mg, cellulosum microcristallinum, povidonum k 25, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, calcii stearas, talcum, macrogolum 6000, hypromellosum, silica colloidalis anhydrica, e 172 (flavum), e 171, pro compresso obducto corresp. natrium 5.18 mg. - la colite ulcéreuse - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - suppositoires - mesalazinum 250 mg, adeps de solidus, pro suppositorio. - la colite ulcéreuse - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - suppositoires - mesalazinum 500 mg, adeps solidus, alcohol cetylicus 18 mg, natrii docusas, pro suppositorio. - la colite ulcéreuse - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - suppositoires - mesalazinum 1000 mg, adeps de solidus, pro suppositorio. - la colite ulcéreuse - synthetika